AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 28 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $272,000 | +532.6% | 25,694 | +340.5% | 0.01% | +250.0% |
Q1 2017 | $43,000 | -90.5% | 5,833 | -94.4% | 0.00% | -93.8% |
Q4 2016 | $451,000 | -32.1% | 103,585 | 0.0% | 0.03% | -25.6% |
Q3 2016 | $664,000 | +28.9% | 103,585 | -2.2% | 0.04% | +19.4% |
Q2 2016 | $515,000 | – | 105,893 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $258,000 | 3.49% |
Aisling Capital Management LP | 1,691,151 | $3,890,000 | 2.10% |
Sio Capital Management, LLC | 871,101 | $2,004,000 | 0.66% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $6,550,000 | 0.64% |
Samsara BioCapital, LLC | 883,720 | $2,033,000 | 0.51% |
Ghost Tree Capital, LLC | 686,599 | $1,579,000 | 0.34% |
Nantahala Capital Management | 3,200,593 | $7,361,000 | 0.33% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 245,678 | $565,000 | 0.29% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,059,894 | $9,338,000 | 0.28% |
Lion Point Capital, LP | 300,000 | $690,000 | 0.16% |